.png)
5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn
Hosted by Dr. Thomas McGinn, Professor, Baylor College of Medicine; Clinical Professor of Medicine at Creighton University School of Medicine; Senior Executive Vice President and Chief Physician Executive Officer, CommonSpirit Health Physician Enterprise. Dr. McGinn brings the latest healthcare news to physicians and advanced practice providers.
5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn
5-Minute Check In: New Developments in Allergy Treatments
•
CommonSpirit Health Physician Enterprise
•
Season 4
•
Episode 11
Guest: Dr. Rajan K. Merchant, Allergy, Asthma, and Clinical Immunology Specialist, Dignity Health Woodland Clinic
- Neffy is the first FDA approved nasal spray epinephrine drug, providing needle-free alternative to EpiPens and similar medicines
- Omalizumab for the treatment of multiple food allergies (References: NEJM article)
- Palforzia and oral immunotherapy for peanut allergies (References: https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300145)